Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. 600613.SS Stock
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Price Chart
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. 600613.SS Financial and Trading Overview
Contents
- Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Price Chart
- Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. 600613.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
- Q&A For Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Stock
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. stock price | 6.18 CNY |
Previous Close | 6.66 CNY |
Open | 6.66 CNY |
Bid | 6.69 CNY x N/A |
Ask | 6.7 CNY x N/A |
Day's Range | 6.63 - 6.73 CNY |
52 Week Range | 4.88 - 14.2 CNY |
Volume | 5.41M CNY |
Avg. Volume | 7.82M CNY |
Market Cap | 3.46B CNY |
Beta (5Y Monthly) | 0.314726 |
PE Ratio (TTM) | 74.33333 |
EPS (TTM) | 0.11 CNY |
Forward Dividend & Yield | 0.1 (1.50%) |
Ex-Dividend Date | July 19, 2022 |
1y Target Est | N/A |
600613.SS Valuation Measures
Enterprise Value | 3.62B CNY |
Trailing P/E | 74.33333 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.452412 |
Price/Book (mrq) | 1.6906748 |
Enterprise Value/Revenue | 1.521 |
Enterprise Value/EBITDA | 20.553 |
Trading Information
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.314726 |
52-Week Change | 14.82% |
S&P500 52-Week Change | 20.43% |
52 Week High | 14.2 CNY |
52 Week Low | 4.88 CNY |
50-Day Moving Average | 7.38 CNY |
200-Day Moving Average | 7.8 CNY |
600613.SS Share Statistics
Avg. Volume (3 month) | 7.82M CNY |
Avg. Daily Volume (10-Days) | 5.66M CNY |
Shares Outstanding | 479.32M |
Float | 289.59M |
Short Ratio | N/A |
% Held by Insiders | 59.78% |
% Held by Institutions | 0.0010% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.1 |
Trailing Annual Dividend Yield | 1.50% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 1.1111 |
Last Split Factor | 12:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 2.04% |
Operating Margin (ttm) | 3.68% |
Gross Margin | 52.09% |
EBITDA Margin | 7.39% |
Management Effectiveness
Return on Assets (ttm) | 1.71% |
Return on Equity (ttm) | 1.98% |
Income Statement
Revenue (ttm) | 2.38B CNY |
Revenue Per Share (ttm) | 4.41 CNY |
Quarterly Revenue Growth (yoy) | -0.89% |
Gross Profit (ttm) | N/A |
EBITDA | 176.35M CNY |
Net Income Avi to Common (ttm) | 48.8M CNY |
Diluted EPS (ttm) | 0.09 |
Quarterly Earnings Growth (yoy) | 1.40% |
Balance Sheet
Total Cash (mrq) | 666.34M CNY |
Total Cash Per Share (mrq) | 1.12 CNY |
Total Debt (mrq) | 284.47M CNY |
Total Debt/Equity (mrq) | 11.86 CNY |
Current Ratio (mrq) | 2.913 |
Book Value Per Share (mrq) | 3.957 |
Cash Flow Statement
Operating Cash Flow (ttm) | 279.91M CNY |
Levered Free Cash Flow (ttm) | 208.39M CNY |
Profile of Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Country | China |
State | N/A |
City | Shanghai |
Address | Changfa Building |
ZIP | 200003 |
Phone | 86 21 5375 0009 |
Website | https://www.gzsq.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 1570 |
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, nourishing and soothing, tonic products, cold and cough, children's medicine, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidate injection, loquat cough granules, strong loquat decoction, loquat cough capsules, jinwugutong capsules, coral ringworm jing, jingwu capsules, quantianma capsules, yindanxintai dropping pills, etc. The company was founded in 1990 and is based in Shanghai, China.
Q&A For Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Stock
What is a current 600613.SS stock price?
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. 600613.SS stock price today per share is 6.18 CNY.
How to purchase Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. stock?
You can buy 600613.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.?
The stock symbol or ticker of Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. is 600613.SS.
Which industry does the Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. company belong to?
The Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. industry is Drug Manufacturers-General.
How many shares does Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. have in circulation?
The max supply of Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. shares is 519.57M.
What is Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. PE Ratio is 56.18181600 now.
What was Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. EPS is 0.11 CNY over the trailing 12 months.
Which sector does the Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. company belong to?
The Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. sector is Healthcare.